Participate in research into the impact of MS suffering, or a study that examines a behavioral intervention to treat insomnia in adults with MS.
Accelerated Cure Project
I AM
Living with MS
A Caregiver
A Researcher
A Healthcare Provider
Interested in Donating
Interested in Volunteering
Living with MS
Take charge of your MS diagnosis through research
Connect with ACP and join the community of those affected by MS driving, shaping, and accelerating MS research. Take an active role in research and contribute to the cure.
A Caregiver
Access the resources you need
At ACP, we recognize the vital role MS caregivers play and the toll the role can take. Connect with us to learn about our caregiver resources and how your participation in research can benefit you and your loved one with MS.
A Researcher
Connect with ACP to accelerate your research
ACP’s resources are available to MS researchers worldwide and are designed to advance your work through access to the biosamples, data, and people you need. Collaborate with ACP through the ACP Repository, iConquerMS, and our Inclusive Engagement initiatives to accelerate your research.
A Healthcare Provider
Provide your patients with the information they need
Your patients and their caregivers may be looking for opportunities to drive, shape, and accelerate MS research. Through iConquerMS and the RIDE Council, ACP offers many ways for people affected by MS to power research.
Interested in Donating
Your financial support accelerates a cure for MS
A gift of any size makes a difference in the fight to cure MS. Your donation to ACP will accelerate the work of scientists around the world who are researching ways to better diagnose, treat, and cure MS.
Interested in Volunteering
Join our team of volunteers and accelerate MS research
Sharing your time and talents is a meaningful way to contribute to accelerating MS research. We will match your experience and interests with our needs and find the right volunteer role for you. Join ACP as we work in collaboration with all affected by MS to advance MS research.
iConquerMS
As the only people-powered network for MS, iConquerMS brings together people affected by MS with researchers, healthcare providers, and funders to drive, shape, and accelerate research. iConquerMS members share their insights, experiences, and health information to prioritize research questions that matter most to them and to work in collaboration with researchers to get answers to those questions.
ACP Repository
Researchers seeking to better understand the causes and mechanisms of MS, and to conduct studies leading to faster diagnoses, better treatments, and a cure for the disease will benefit from accessing the high quality blood samples and data in the ACP Repository. Collected from over 3,200 participants diagnosed with MS, related demyelinating diseases, and healthy controls, the samples and data are available to any scientist worldwide.
Inclusive Research Engagement
Research evidence that can benefit all affected by MS can only be achieved when the research itself reflects the diversity of people living with MS. ACP has the expertise and resources to assist you in addressing minority underrepresentation in your research.
What's New
The iConquerMS community has contributed to many research studies on a wide variety of topics, with more to come!
Your support enables groundbreaking discoveries through the ACP Repository.
Not enough time to read an entire newsletter? Our September newsletter snapshot contains the highlights in a quick, easy to read format.
We are thrilled to welcome Dr. Stephanie Buxhoeveden to the ACP team, spend a moment getting to know her!
Leading researchers are uncovering new biomarkers for MS using samples and data from the ACP Repository. Discover the latest breakthroughs with us!
Not enough time to read an entire newsletter? Our August newsletter snapshot contains the highlights in a quick, easy to read format.
Research studies include one for Kesimpta users, exploration into childhood experiences, and a study on exercise and wellness for wheelchair users.